Search research articles
Contact Us
Filters
Showing results (1481-1490 of 1,668) with videos related to
Page
of 167
Sort By:
Hematology/Oncology and Stem Cell Therapy
|
March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Cancers
|
June 24, 2022
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Astrid E Slagter, Irene A Caspers, Nicole C T van Grieken, et al.
Genome Medicine
|
May 19, 2021
Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C de Jong, et al.
Analytical Biochemistry
|
May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Esther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
BMC Cancer
|
April 9, 2020
Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material
Elisabeth M P Steeghs, Leonie I Kroeze, Bastiaan B J Tops, et al.
Journal of Surgical Oncology
|
December 11, 2023
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial
Irene A Caspers, Astrid E Slagter, Pehr Lind, et al.
Eclinicalmedicine
|
August 21, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study
Lissa Wullaert, Maurice P H M Jansen, Jaco Kraan, et al.
Haematologica
|
May 9, 2024
Anti-T-lymphocyte globulin exposure is associated with acute graft-<i>versus</i>-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study
Lisa V E Oostenbrink, Erik G J Von Asmuth, Cornelia M Jol-van der Zijde, et al.
Journal of Crohn'S & Colitis
|
June 13, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
Fenna M Jansen, Reinier C A van Linschoten, Wietske Kievit, et al.
Digestive Diseases and Sciences
|
April 9, 2024
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Page
of 167
Search research articles
Search
Showing results (1481-1490 of 1,668) with videos related to
Sort By:
Page
of 167
Hematology/Oncology and Stem Cell Therapy
|
March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Cancers
|
June 24, 2022
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Astrid E Slagter, Irene A Caspers, Nicole C T van Grieken, et al.
Genome Medicine
|
May 19, 2021
Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C de Jong, et al.
Analytical Biochemistry
|
May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Esther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
BMC Cancer
|
April 9, 2020
Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material
Elisabeth M P Steeghs, Leonie I Kroeze, Bastiaan B J Tops, et al.
Journal of Surgical Oncology
|
December 11, 2023
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial
Irene A Caspers, Astrid E Slagter, Pehr Lind, et al.
Eclinicalmedicine
|
August 21, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study
Lissa Wullaert, Maurice P H M Jansen, Jaco Kraan, et al.
Haematologica
|
May 9, 2024
Anti-T-lymphocyte globulin exposure is associated with acute graft-<i>versus</i>-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study
Lisa V E Oostenbrink, Erik G J Von Asmuth, Cornelia M Jol-van der Zijde, et al.
Journal of Crohn'S & Colitis
|
June 13, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
Fenna M Jansen, Reinier C A van Linschoten, Wietske Kievit, et al.
Digestive Diseases and Sciences
|
April 9, 2024
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Page
of 167